Packaging & Paper Global On demand · 24-48h

Global Blister Packaging Equipment for Pharmaceutical Market Strategic Research Report

Global Blister Packaging Equipment for Pharmaceutical Market…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Blister Packaging Equipment for Pharmaceutical Market
$6972025
5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Low Speed, Medium Speed, High Speed

By Application: Tablets, Capsules, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Uhlmann, IMA Group, Marchesini, Romaco, Körber Pharma, Pharmaworks, Hoong-A, CAM, Mutual Corporation, ACG Pam Pac, Algus Packaging, Hualian Pharmaceutical Machinery, Jornen Machinery, Lodha International, Yangzhou Nuoya Machinery, Jinzhou Wonder Packing Machinery, Visual Packaging, Zhejiang Hope Machinery

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 134 pages
Market size 2025
$697
Million USD
Forecast CAGR
5%
2025-2032
Forecast 2032
$980.7
Projected
リージョン
5
Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global Blister Packaging Equipment for Pharmaceutical market size is predicted to grow from US$ 697 million in 2025 to US$ 979 million in 2032; it is expected to grow at a CAGR of 5.0% from 2026 to 2032.

The blister packaging equipment for pharmaceutical use is a specialized device for blister packaging of pharmaceutical products, capable of achieving efficient, precise, and safe packaging of medications. Depending on the nature of the medication, different packaging processes (thermoforming or cold forming) are selected to seal the medication between aluminum-plastic blisters or double-layered aluminum foil blisters. It is widely used in the packaging of various tablets, capsules, and other medications, ensuring the safety and effectiveness of the pharmaceuticals. In 2025, global Blister Packaging Equipment for Pharmaceutical production reached approximately 10,171 units, with an average global market price of around 70 K US$/Unit. The production capacity of Blister Packaging Equipment for Pharmaceutical reaches 13,560 units, and the industry's gross profit margin is approximately between 25% and 45%.

Pharmaceutical blister packaging equipment has evolved from standalone forming and sealing units into integrated automated packaging systems that combine thermoforming or cold forming, automatic feeding, vision inspection, heat sealing, coding, die-cutting, rejection, serialization and traceability, cartoning line integration, and data recording capabilities. Current mainstream demand is concentrated in packaging applications for tablets, capsules, softgels, OTC medications, prescription drugs, clinical samples, and select medical consumables. Industry growth is primarily driven by factors such as the global expansion of solid dosage manufacturing capacity, increased consumption of generic and OTC drugs, heightened requirements for pharmaceutical safety and moisture barrier protection, pharmaceutical companies' pursuit of GMP compliance and production efficiency upgrades, rising demand for high-barrier aluminum-aluminum packaging, and the widespread adoption of integrated cartoning lines and serialization traceability systems. Large pharmaceutical enterprises tend to prioritize the procurement of high-speed, integrated blister-to-carton lines to boost production capacity, minimize manual labor, and reduce packaging errors; conversely, small and medium-sized pharmaceutical companies and CDMOs place greater emphasis on rapid changeover capabilities, material compatibility, and the capacity for multi-variety, small-batch production. Moving forward, pharmaceutical blister packaging equipment will continue to evolve toward higher speeds, greater flexibility, intelligent inspection, data traceability, energy efficiency, and compatibility with sustainable packaging materials. While the high-end market remains dominated by manufacturers from Europe and North America, the mid-to-low-end and standardized equipment segments are being rapidly filled by manufacturers from China, India, and other Asian regions.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Blister Packaging Equipment for Pharmaceutical market?

What factors are driving Blister Packaging Equipment for Pharmaceutical market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Blister Packaging Equipment for Pharmaceutical market opportunities vary by end market size?

How does Blister Packaging Equipment for Pharmaceutical break out by Type, by Application?

This report presents a comprehensive overview of the global Blister Packaging Equipment for Pharmaceutical market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Low Speed
  • Medium Speed
  • High Speed

Segment by Automation

  • Fully Automatic
  • Semi-Automatic

Segment by Process

  • Continuous Blister Packaging Equipment
  • Intermittent Blister Packaging Equipment

Segment by Application

  • Tablets
  • Capsules
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Blister Packaging Equipment for Pharmaceutical market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Tablets, Capsules, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Blister Packaging Equipment for Pharmaceutical Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$697
2025
Forecast
$980.7
2032
CAGR
5%
2025–2032
リージョン
5
global
Key companies
UhlmannIMA GroupMarchesiniRomacoKörber PharmaPharmaworksHoong-ACAM
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Low SpeedMedium SpeedHigh Speed
By Application
TabletsCapsulesOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Low Speed
  • 3.1.3 Medium Speed
  • 3.1.4 High Speed
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Tablets
  • 4.1.3 Capsules
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Uhlmann
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 IMA Group
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Marchesini
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Romaco
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Körber Pharma
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Pharmaworks
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Hoong-A
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 CAM
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Mutual Corporation
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 ACG Pam Pac
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Algus Packaging
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Hualian Pharmaceutical Machinery
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Jornen Machinery
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Lodha International
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Yangzhou Nuoya Machinery
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Jinzhou Wonder Packing Machinery
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Visual Packaging
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Zhejiang Hope Machinery
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Blister Packaging Equipment for Pharmaceutical market?
The global Blister Packaging Equipment for Pharmaceutical market is estimated at US$ 697 million in 2025 (base year) and is projected to reach US$ 979 million by 2032.
How fast is the Blister Packaging Equipment for Pharmaceutical market expected to grow?
The market is expected to grow at a CAGR of 5.0% from 2026 to 2032, expanding from US$ 697 million in 2025 to US$ 979 million in 2032, roughly 1.4 times its base-year value.
What does the Blister Packaging Equipment for Pharmaceutical market cover?
The blister packaging equipment for pharmaceutical use is a specialized device for blister packaging of pharmaceutical products, capable of achieving efficient, precise, and safe packaging of medications. Depending on the nature of the medication, different packaging processes (thermoforming or cold forming) are selected to seal the medication between aluminum-plastic blisters or double-layered aluminum foil blisters.
What are the main segments of the Blister Packaging Equipment for Pharmaceutical market by type?
By type, the market is segmented into Low Speed, Medium Speed and High Speed.
Which applications drive demand in the Blister Packaging Equipment for Pharmaceutical market?
Key applications covered include Tablets, Capsules and Others.
Who are the key players in the Blister Packaging Equipment for Pharmaceutical market?
Key players profiled include Uhlmann, IMA Group, Marchesini, Romaco, Körber Pharma, Pharmaworks, Hoong-A and CAM, among 18 companies covered in total.
Which regions and countries are covered for Blister Packaging Equipment for Pharmaceutical?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Blister Packaging Equipment for Pharmaceutical market?
What factors are driving Blister Packaging Equipment for Pharmaceutical market growth, globally and by region?
Who should buy the Blister Packaging Equipment for Pharmaceutical market report?
The report is intended for manufacturers and solution providers, distributors and end users in Tablets, Capsules and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Blister Packaging Equipment for Pharmaceutical market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600